4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

4 - HUMANA INC (0000049071) (Issuer)

Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stockholders of record as of the close of business on March 28, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military se

Reports 4Q24 net loss per share of $5.76 on a GAAP basis, Adjusted net loss per share of $2.16; reports FY 2024 earnings per share (EPS) of $9.98 on a GAAP basis, $16.21 on an Adjusted basis 4Q24 Insurance segment Adjusted benefit ratio of 91.9 percent, which includes a 20-basis point increase related to incremental Star Ratings investments, was consistent with expectations Affirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence Expects individual Medicare Advantage annua

Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2024 (4Q24), as well as prepared management remarks (in PDF format), on Tuesday, February 11, 2025, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BIe3b4c275f3cf421383fa6ac8a142593b. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique re

AM Best has downgraded the Financial Strength Rating (FSR) to B+ (Good) from B++ (Good) and the Long-Term Issuer Credit Rating (Long-Term ICR) to "bbb-" (Good) from "bbb" (Good) of Humana Insurance of Puerto Rico, Inc. and Humana Health Plans of Puerto Rico, Inc. These companies are domiciled in Puerto Rico and collectively are referred to as Humana Health of Puerto Rico Group. The outlook of these Credit Ratings (ratings) has been revised to negative from stable. Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These sub

Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $4.16; reports YTD 2024 EPS of $15.72 on a GAAP basis, $18.35 on an Adjusted basis Updates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis, 'at least $16.00' on an Adjusted basis; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 40,000 to now anticipate annual growth of approximately 265,000, or approximately 5 percent Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for

Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 31, 2025 to stockholders of record as of the close of business on December 31, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, milita

Humana Inc. (NYSE:HUM) will release its financial results for the third quarter 2024 (3Q24), as well as prepared management remarks (in PDF format), on Wednesday, October 30, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI66effa11b1e4494d907df29b87d7d237. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi

Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil

Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 75,000 to now anticipate annual growth of approximately 225,000, or 4.2 percent Publishes Letter from the CEO and prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00

Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

SC 13G - HUMANA INC (0000049071) (Subject)

SC 13G/A - HUMANA INC (0000049071) (Subject)

BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously

KeyBanc Capital Markets initiated coverage of Humana with a rating of Sector Weight

Bernstein upgraded Humana from Mkt Perform to Outperform and set a new price target of $308.00

TD Cowen downgraded Humana from Buy to Hold and set a new price target of $261.00 from $402.00 previously

Jefferies downgraded Humana from Buy to Hold and set a new price target of $253.00 from $519.00 previously

Piper Sandler downgraded Humana from Overweight to Neutral and set a new price target of $274.00 from $392.00 previously

BofA Securities downgraded Humana from Neutral to Underperform and set a new price target of $247.00 from $376.00 previously

Leerink Partners downgraded Humana from Outperform to Market Perform and set a new price target of $250.00 from $400.00 previously

Stephens downgraded Humana from Overweight to Equal-Weight and set a new price target of $250.00 from $400.00 previously

Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00

4 - HUMANA INC (0000049071) (Issuer)

Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that Celeste Mellet will be appointed to succeed Susan Diamond as Chief Financial Officer (CFO), effective January 11, 2025. Diamond is stepping down after a successful 18-year career at Humana, including over three years as CFO, and will serve in an advisory role through the end of 2025 to ensure a smooth transition. "On behalf of the entire Board and management team, I want to extend my thanks to Susan for her leadership as CFO and in prior roles during her nearly two decades at Humana," said Jim Rechtin, Humana's President and Chief Executive Officer. "Susan's contributions spanned across our Medicare, Home So

Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O'Hara will oversee the enterprise talent strategy and people programs for Humana's more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively attract, recruit, develop and retain a talented and diverse workforce. O'Hara will report directly to Humana President and CEO Jim Rechtin. "Humana's people strategy is a core capability for our business that supports and empowers our workforce so they can successfully deliver on our mission to make it easier

The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companie

David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years

Broussard, who reimagined senior-focused health care, announces he will step down after more than a decade of serving at the helm of the company Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Over the last decade, he has led the company's transformati

The Humana Foundation, philanthropic arm of Humana Inc. (NYSE:HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023. Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023. "I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation's reach has expanded nationally," said Mr.

CenterWell Senior Primary Care® is celebrating the grand opening of its new center located next to the Walmart in Gladstone, Missouri, March 26, from 10 a.m. to 1 p.m. This is the first grand opening event of the 23 centers at Walmart locations across four states scheduled to open by the middle of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250320366966/en/CenterWell Senior Primary Care in Gladstone, Mo., will celebrate its grand opening March 26. This is the first event for the 23 locations across four states where Humana's primary care brands, CenterWell Senior Primary Care and Conviva Senior Primary Care, are ope

Specialty care model introduced first in Palm Beach County LOUISVILLE, Ky. and STAMFORD, Conn., March 17, 2025 /PRNewswire/ -- Senior-focused primary care providers CenterWell Senior Primary Care® and Conviva Senior Primary Care® are now partnering with Icon Health, a leading provider of value-based musculoskeletal healthcare, to provide seniors with convenient access to quality, integrated musculoskeletal care in their primary care centers. Musculoskeletal conditions, including back pain, arthritis, and joint injuries, are among the primary causes of disability in the senior

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount, and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $1.231 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior

AM Best has assigned a Long-Term Issue Credit Rating of "bbb" (Good) to the $750 million, 5.5% senior unsecured notes, due 2035, and the $500 million, 6.0% senior unsecured notes, due 2055, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of "bbb" (Good), its Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. Humana expects to use the proceeds from the senior unsecured notes issuance for general corporate purposes, including the repayment of existing debt of $600 million, 4.5% senior unsecured notes maturing in April 2025, and short-t

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on March 5, 2025, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings will be approximately $1.231 billion after

Humana Inc. (NYSE:HUM), a leading health and well-being company, today introduced a new value-based care agreement with Thyme Care to provide comprehensive cancer care support for eligible Humana Medicare Advantage members. Value-based care is a holistic, patient-centered model designed to improve patient health outcomes and quality of life while helping to make healthcare more affordable and accessible. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226867807/en/ Cancer is the second-leading cause of death in the United States, with devastating physical, emotional, and financial consequences. Humana's collaboration with Thym

The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern Kentucky. Following the flooding, some areas were also hit by winter snowstorm activity. Over the past week, torrential rains fell across Kentucky causing flooding in some areas while overflowing rivers onto neighborhoods and communities. At least 14 people died due to storm-related issues in Eastern Kentucky. Across the storm's path, especially in areas like Pike and Madison Counties, many people have been displaced and are without clean drinking water. Emergency and disaster response officials h

Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stockholders of record as of the close of business on March 28, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military se

Humana's primary care brands, CenterWell and Conviva, plan to add senior primary care centers in 11 currently served states and four new metro areas Leading senior-focused primary care provider CenterWell Senior Primary Care® intends to continue expanding in 2025, with plans to open centers in new metro areas, including Augusta and Savannah, Georgia; the Triad Region (Burlington, Greensboro and Winston Salem) in North Carolina; and Wichita, Kansas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219895777/en/CenterWell River Hills, located in Asheville, N.C., celebrated its grand opening in June 2024. CenterWell Senior Primary

Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare Advantage members in Alabama, Louisiana, Mississippi, Tennessee, and now Georgia with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) will have access to Monogram's evidence-based nephrology and multispecialty value-based care in the comfort of their homes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213062933/en/ Value-based care focuses on the collaboration and coordination of all aspects of a patient's care, and th